%A Wang Jiangtao, Guan Tao, Su Liping %T Immunotherapy for lymphoma %0 Journal Article %D 2017 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2017.08.020 %P 633-637 %V 44 %N 8 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_10295.shtml} %8 2017-08-08 %X At present, immunotherapies for lymphoma are becoming gradually important. Chimeric antigen receptormodified T cells therapy, bispecific antibody and immunecheckpoint inhibitor are considered as breakthrough treatments, each has its own unique mechanism, and more advanced treatments will be developed based on them.